Binding of apolipoprotein E inhibits the oligomer growth of amyloid beta peptide in solution as determined by fluorescence cross correlation spectroscopy

Ly S, Altman R, Petrlova J, Lin Y, Hilt S, Huser T, Laurence T, Voss J (2013)
Journal of Biological Chemistry 288(17): 11628-11635.

Download
No fulltext has been uploaded. References only!
Journal Article | Original Article | Published | English

No fulltext has been uploaded

Author
; ; ; ; ; ; ;
Publishing Year
ISSN
eISSN
PUB-ID

Cite this

Ly S, Altman R, Petrlova J, et al. Binding of apolipoprotein E inhibits the oligomer growth of amyloid beta peptide in solution as determined by fluorescence cross correlation spectroscopy. Journal of Biological Chemistry. 2013;288(17):11628-11635.
Ly, S., Altman, R., Petrlova, J., Lin, Y., Hilt, S., Huser, T., Laurence, T., et al. (2013). Binding of apolipoprotein E inhibits the oligomer growth of amyloid beta peptide in solution as determined by fluorescence cross correlation spectroscopy. Journal of Biological Chemistry, 288(17), 11628-11635. doi:10.1074/jbc.m112.411900
Ly, S., Altman, R., Petrlova, J., Lin, Y., Hilt, S., Huser, T., Laurence, T., and Voss, J. (2013). Binding of apolipoprotein E inhibits the oligomer growth of amyloid beta peptide in solution as determined by fluorescence cross correlation spectroscopy. Journal of Biological Chemistry 288, 11628-11635.
Ly, S., et al., 2013. Binding of apolipoprotein E inhibits the oligomer growth of amyloid beta peptide in solution as determined by fluorescence cross correlation spectroscopy. Journal of Biological Chemistry, 288(17), p 11628-11635.
S. Ly, et al., “Binding of apolipoprotein E inhibits the oligomer growth of amyloid beta peptide in solution as determined by fluorescence cross correlation spectroscopy”, Journal of Biological Chemistry, vol. 288, 2013, pp. 11628-11635.
Ly, S., Altman, R., Petrlova, J., Lin, Y., Hilt, S., Huser, T., Laurence, T., Voss, J.: Binding of apolipoprotein E inhibits the oligomer growth of amyloid beta peptide in solution as determined by fluorescence cross correlation spectroscopy. Journal of Biological Chemistry. 288, 11628-11635 (2013).
Ly, Sonny, Altman, Robin, Petrlova, Jitka, Lin, Y., Hilt, S., Huser, Thomas, Laurence, Ted, and Voss, John. “Binding of apolipoprotein E inhibits the oligomer growth of amyloid beta peptide in solution as determined by fluorescence cross correlation spectroscopy”. Journal of Biological Chemistry 288.17 (2013): 11628-11635.
This data publication is cited in the following publications:
This publication cites the following data publications:

14 Citations in Europe PMC

Data provided by Europe PubMed Central.

Amyloid-β and tau complexity - towards improved biomarkers and targeted therapies.
Polanco JC, Li C, Bodea LG, Martinez-Marmol R, Meunier FA, Götz J., Nat Rev Neurol 14(1), 2018
PMID: 29242522
Clusterin Binds to Aβ1-42 Oligomers with High Affinity and Interferes with Peptide Aggregation by Inhibiting Primary and Secondary Nucleation.
Beeg M, Stravalaci M, Romeo M, Carrá AD, Cagnotto A, Rossi A, Diomede L, Salmona M, Gobbi M., J Biol Chem 291(13), 2016
PMID: 26884339
Study of Exosomes Shed New Light on Physiology of Amyloidogenesis.
van Niel G., Cell Mol Neurobiol 36(3), 2016
PMID: 26983829
Kinesin-1 inhibits the aggregation of amyloid-β peptide as detected by fluorescence cross-correlation spectroscopy.
Zheng Y, Tian S, Peng X, Yang J, Fu Y, Jiao Y, Zhao J, He J, Hong T., FEBS Lett 590(7), 2016
PMID: 26991731
ApoE: the role of conserved residues in defining function.
Frieden C., Protein Sci 24(1), 2015
PMID: 25377861
Chronic Microdose Lithium Treatment Prevented Memory Loss and Neurohistopathological Changes in a Transgenic Mouse Model of Alzheimer's Disease.
Nunes MA, Schöwe NM, Monteiro-Silva KC, Baraldi-Tornisielo T, Souza SI, Balthazar J, Albuquerque MS, Caetano AL, Viel TA, Buck HS., PLoS One 10(11), 2015
PMID: 26605788
Soluble apoE/Aβ complex: mechanism and therapeutic target for APOE4-induced AD risk.
Tai LM, Mehra S, Shete V, Estus S, Rebeck GW, Bu G, LaDu MJ., Mol Neurodegener 9(), 2014
PMID: 24386905
Total apolipoprotein E levels and specific isoform composition in cerebrospinal fluid and plasma from Alzheimer's disease patients and controls.
Martínez-Morillo E, Hansson O, Atagi Y, Bu G, Minthon L, Diamandis EP, Nielsen HM., Acta Neuropathol 127(5), 2014
PMID: 24633805
Amyloid-β pathology and APOE genotype modulate retinoid X receptor agonist activity in vivo.
Tai LM, Koster KP, Luo J, Lee SH, Wang YT, Collins NC, Ben Aissa M, Thatcher GR, LaDu MJ., J Biol Chem 289(44), 2014
PMID: 25217640
The binding of apolipoprotein E to oligomers and fibrils of amyloid-β alters the kinetics of amyloid aggregation.
Garai K, Verghese PB, Baban B, Holtzman DM, Frieden C., Biochemistry 53(40), 2014
PMID: 25207746
Pharmacological inhibition of dynamin II reduces constitutive protein secretion from primary human macrophages.
Kockx M, Karunakaran D, Traini M, Xue J, Huang KY, Nawara D, Gaus K, Jessup W, Robinson PJ, Kritharides L., PLoS One 9(10), 2014
PMID: 25347775
On the subject of rigor in the study of amyloid β-protein assembly.
Teplow DB., Alzheimers Res Ther 5(4), 2013
PMID: 23981712

52 References

Data provided by Europe PubMed Central.

Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium.
Farrer LA, Cupples LA, Haines JL, Hyman B, Kukull WA, Mayeux R, Myers RH, Pericak-Vance MA, Risch N, van Duijn CM., JAMA 278(16), 1997
PMID: 9343467

Export

0 Marked Publications

Open Data PUB

Web of Science

View record in Web of Science®

Sources

PMID: 23430745
PubMed | Europe PMC

Search this title in

Google Scholar